Orthocell Limited Company Profile

Orthocell is a commercial-stage, regenerative medicine company focused
on regenerating mobility for patients and our ageing population by
developing products for a variety of tendon, cartilage and soft tissue
injuries. Orthocellâs portfolio of products include TGA-approved stem
cell therapies Autologous Tenocyte Implantation (Ortho-ATIâ¢) and
Autologous Chondrocyte Implantation (Ortho-ACIâ¢), which aim to
regenerate damaged tendon and cartilage tissue. The Companyâs other
major product is Celgroâ¢, a collagen medical device which facilitates
tissue repair and healing in a variety of orthopaedic, reconstructive
and surgical applications and is being readied for first regulatory
approvals.

Oxford, UK, 1 November 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs, announces the appointment of Christine...

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...